CRISPR Therapeutics AG is a long-term buy despite slow Casgevy uptake. Click for my updated look at CRSP earnings and the ...

From shocking outliers to budget-friendly powerhouses, we've learned which cordless vacuums truly excel in battery life, ...

Initial $75 million to fund the potential U.S. commercial launch of obexelimab for the treatment of IgG4-Related Disease - ...

On track to deliver Portfolio Receipts of $4.7 billion or more by 2030, significantly ahead of consensus Goal to achieve at least mid-teens ...

Beam Therapeutics Inc. ( NASDAQ: BEAM) Citi's Biopharma Back to School Conference September 3, 2025 4:00 PM EDT ...

Forensic pathologist Dr Jessie Hiu of the Queen Elizabeth Hospital testified as the first witness on Wednesday (Sept 3) ...

Big Tech companies have been rolling out tools to enable developers in recognition of them as co-architects of agentic AI.

This is the ultimate deep dive into the mystical world of bending from the iconic series, Avatar: The Last Airbender! Also, score your grail toy today from BigBadToyStore at As anticipation builds for ...

DM1 results from a CTG repeat expansion in the DMPK gene, with disease severity linked to the number of repeats (symptoms usually appear with over 50). The disorder also demonstrates anticipation, ...

Next, consider Nvidia; Jensen Huang understands the logic of "selling shovels in the AI era" exceptionally well, but he is not just selling hardware; he has taken the "shovel" to the extreme. The ...

Vertex Pharmaceuticals Incorporated just reported a robust Q2 with earnings per share of $4.52, surpassing estimates and ...